Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-017-1049-z ◽

2017 ◽

Vol 54 (11) ◽

pp. 1069-1071

Author(s):

Ilaria Dicembrini ◽

Besmir Nreu ◽

Alessia Scatena ◽

Francesco Andreozzi ◽

Giorgio Sesti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-017-1031-9 ◽

2017 ◽

Vol 54 (10) ◽

pp. 933-941 ◽

Cited By ~ 29

Author(s):

Ilaria Dicembrini ◽

Besmir Nreu ◽

Alessia Scatena ◽

Francesco Andreozzi ◽

Giorgio Sesti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon‐like peptide‐1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.3168 ◽

2019 ◽

Vol 35 (7) ◽

Cited By ~ 4

Author(s):

Liang Cheng ◽

Yun Hu ◽

Yun‐Yun Li ◽

Xin Cao ◽

Ning Bai ◽

...

Keyword(s):

Type 2 Diabetes ◽

Bone Fracture ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/s41598-017-16018-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Fang Zhang ◽

Lizhi Tang ◽

Yuwei Zhang ◽

Qingguo Lü ◽

Nanwei Tong

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Diabetes Patients

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.12541 ◽

2015 ◽

Vol 17 (11) ◽

pp. 1065-1074 ◽

Cited By ~ 31

Author(s):

T. Karagiannis ◽

A. Liakos ◽

E. Bekiari ◽

E. Athanasiadou ◽

P. Paschos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Effect of glucagon-like peptide-1 on major cardiovascular outcomes in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.07.199 ◽

2016 ◽

Vol 222 ◽

pp. 957-962 ◽

Cited By ~ 11

Author(s):

Song Ding ◽

Yong-ping Du ◽

Nan Lin ◽

Yuan-yuan Su ◽

Fan Yang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Impact of glucagon‐like peptide‐1 receptor agonists on adiponectin concentrations: a meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14855 ◽

2021 ◽

Author(s):

Luis E. Simental‐Mendía ◽

Adriana Sánchez‐García ◽

Enrique Linden‐Torres ◽

Mario Simental‐Mendía

Keyword(s):

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.12926 ◽

2017 ◽

Vol 19 (9) ◽

pp. 1233-1241 ◽

Cited By ~ 62

Author(s):

Matteo Monami ◽

Besmir Nreu ◽

Alessia Scatena ◽

Barbara Cresci ◽

Francesco Andreozzi ◽

...

Keyword(s):

Pancreatic Cancer ◽

Controlled Trials ◽

Safety Issues ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review4 ◽

2019 ◽

Keyword(s):

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽